section name header

Evidence summaries

Interventions for Chronic Palmoplantar Pustulosis

Oralretinoids, especially when combined with psoralens and PUVA may be beneficial in chronic palmoplantar pustulosis but no treatment has been shown to suppress the condition completely. Level of evidence: "C"

A Cochrane review [Abstract] 1 included 23 studies with a total of 724 subjects. Evidence supports the use of systemic retinoids (improvement rate difference 44%, 95 CI 28 to 59%), oral PUVA (improvement rate difference 44%, 95 CI 26 to 62%). A combination of PUVA and retinoids is better than the individual treatments. The use of topical steroid under hydrocolloid occlusion is beneficial. Low dose ciclosporin, tetracycline antibiotics and Grenz Ray Therapy may be useful in treating PPP. Colchicine has a lot of side effects and it is unclear if it is effective and neither was topical PUVA (rate difference of 0.00, 95% CI -0.04 to +0.04). There is no evidence to suggest that short-term treatment with hydroxycarbamide (hydroxyurea) is effective.

Comment: The quality of evidence is downgraded by imprecise results (limited study size for each comparison) and by limitations in study quality (e.g., inadequate follow up).

    References

    • Marsland AM, Chalmers RJ, Hollis S, Leonardi-Bee J, Griffiths CE. Interventions for chronic palmoplantar pustulosis. Cochrane Database Syst Rev 2006 Jan 25;(1):CD001433. [PubMed]

Primary/Secondary Keywords